128 related articles for article (PubMed ID: 22629)
1. The actions of neuroleptic drugs and putative serotonin receptor antagonists on LSD and quipazine-induced reductions of brain 5-HIAA concentrations.
Jacoby JH; Poulakos JJ
J Pharm Pharmacol; 1977 Dec; 29(12):771-3. PubMed ID: 22629
[No Abstract] [Full Text] [Related]
2. The effect of quipazine and LSD on monoamines in the rat striatum.
Miśkiewicz M; Rokosz-Pelc A; Vetulani J
Pol J Pharmacol Pharm; 1979; 31(5):489-92. PubMed ID: 94944
[TBL] [Abstract][Full Text] [Related]
3. Quipazine-induced stimulus control in the rat.
Winter JC
Psychopharmacology (Berl); 1979 Feb; 60(3):265-9. PubMed ID: 108704
[No Abstract] [Full Text] [Related]
4. A behavioural and biochemical study in rats of 5-hydroxytryptamine receptor agonists and antagonists, with observations on structure-activity requirements for the agonists.
Green AR; Hall JE; Rees AR
Br J Pharmacol; 1981 Jul; 73(3):703-19. PubMed ID: 6166345
[TBL] [Abstract][Full Text] [Related]
5. The influence of quipazine on the turnover rate of serotonin.
Grabowska M; Antkiewicz L; Michaluk J
Biochem Pharmacol; 1974 Nov; 23(22):3211-2. PubMed ID: 4441411
[No Abstract] [Full Text] [Related]
6. Effects of quipazine on pre- and postsynaptic serotonin receptors: single cell studies in the rat CNS.
Blier P; de Montigny C
Neuropharmacology; 1983 Apr; 22(4):495-9. PubMed ID: 6856049
[TBL] [Abstract][Full Text] [Related]
7. Quipazine induced wet dog shake behaviour in rats: mechanism of action.
Hiremagalur ; Keshavan JH; Dandiya PC; Gurbani NK
Pharmacol Res Commun; 1980 Sep; 12(8):757-68. PubMed ID: 6160597
[No Abstract] [Full Text] [Related]
8. Head twitches induced by LSD and quipazine: similarities and differences.
Vetulani J; Bednarczyk B; Reichenberg K; Rokosz A
Neuropharmacology; 1980 Feb; 19(2):155-8. PubMed ID: 6244515
[No Abstract] [Full Text] [Related]
9. Substituted piperazines as central serotonin agonists: comparative specificity of the postsynaptic actions of quipazine and m-trifluoromethylphenylpiperazine.
Fuller RW; Snoddy HD; Mason NR; Hemrick-Luecke SK; Clemens JA
J Pharmacol Exp Ther; 1981 Sep; 218(3):636-41. PubMed ID: 6167711
[No Abstract] [Full Text] [Related]
10. Discriminative stimulus properties of quipazine: mediation by serotonin2 binding sites.
Friedman RL; Barrett RJ; Sanders-Bush E
J Pharmacol Exp Ther; 1984 Mar; 228(3):628-35. PubMed ID: 6707913
[TBL] [Abstract][Full Text] [Related]
11. Drug-induced stimulus control and the concept of breaking point: LSD and quipazine.
Winter JC
Psychopharmacology (Berl); 1981; 72(2):217-8. PubMed ID: 6782615
[TBL] [Abstract][Full Text] [Related]
12. Serotonin1c receptor reserve in choroid plexus masks receptor subsensitivity.
Sanders-Bush E; Breeding M
J Pharmacol Exp Ther; 1990 Mar; 252(3):984-8. PubMed ID: 2319481
[TBL] [Abstract][Full Text] [Related]
13. Behavioral effects of quipazine in the cat.
Trulson ME; Brandstetter JW; Crisp T; Jacobs BL
Eur J Pharmacol; 1982 Mar; 78(3):295-305. PubMed ID: 6461558
[TBL] [Abstract][Full Text] [Related]
14. Modification of apomorphine hypothermia by drugs affecting brain 5-hydroxytryptamine function.
Menon MK; Vivonia CA
Eur J Pharmacol; 1981 Dec; 76(2-3):223-7. PubMed ID: 7333357
[TBL] [Abstract][Full Text] [Related]
15. Brain serotonin metabolism after tolerance dosage of LSD.
Freedman DX; Boggan WO
Adv Biochem Psychopharmacol; 1974; 10():151-7. PubMed ID: 4846536
[No Abstract] [Full Text] [Related]
16. Mechanisms by which quipazine, a putative serotonin receptor agonist, alters brain 5-hydroxyindole metabolism.
Jacoby JH; Howd RA; Levin MS; Wurtman RJ
Neuropharmacology; 1976 Sep; 15(9):529-34. PubMed ID: 980228
[No Abstract] [Full Text] [Related]
17. [Quipazine antagonizing baclofen activity. Influence of baclofen and gamma-hydroxybutyric acid on serotonin metabolism in rat brain (author's transl)].
Waldmeier PC; Maître L
Arzneimittelforschung; 1978; 28(9):1507-8. PubMed ID: 582544
[TBL] [Abstract][Full Text] [Related]
18. Local cerebral glucose utilisation following indoleamine- and piperazine-containing 5-hydroxytryptamine agonists.
Grome JJ; Harper AM
J Neurochem; 1986 Jan; 46(1):117-24. PubMed ID: 3940273
[TBL] [Abstract][Full Text] [Related]
19. Lysergic acid diethylamide (LSD) and lisuride: differentiation of their neuropharmacological actions.
White FJ; Appel JB
Science; 1982 Apr; 216(4545):535-7. PubMed ID: 7071600
[TBL] [Abstract][Full Text] [Related]
20. Naloxone alters the effects of LSD, DOM and quipazine on operant behavior of rats.
Mokler DJ; Commissaris RL; Henck JW; Rech RH
Pharmacol Biochem Behav; 1984 Sep; 21(3):333-7. PubMed ID: 6593750
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
